These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24984902)

  • 1. Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?
    Scheuing N; Badenhoop K; Borkenstein M; Konrad K; Lilienthal E; Laubner K; Naeke A; Rami-Merhar B; Thon A; Wiemann D; Holl RW;
    Pediatr Diabetes; 2015 Feb; 16(1):10-5. PubMed ID: 24984902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate intake and insulin requirement in children, adolescents and young adults with cystic fibrosis-related diabetes: A multicenter comparison to type 1 diabetes.
    Scheuing N; Thon A; Konrad K; Bauer M; Karsten C; Meissner T; Seufert J; Schönau E; Schöfl C; Woelfle J; Holl RW;
    Clin Nutr; 2015 Aug; 34(4):732-8. PubMed ID: 25245859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does β-Cell Autoimmunity Play a Role in Cystic Fibrosis-Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry.
    Konrad K; Kapellen T; Lilienthal E; Prinz N; Bauer M; Thon A; Rietschel E; Wiemann D; Holl RW;
    Diabetes Care; 2016 Aug; 39(8):1338-44. PubMed ID: 27271187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sensor-augmented insulin pump in patient with diabetes and cystic fibrosis: evidence for improvement in metabolic control.
    Klupa T; Małecki M; Katra B; Cyganek K; Skupień J; Kostyk E; Pietrzyk J; Sieradzki J
    Diabetes Technol Ther; 2008 Feb; 10(1):46-9. PubMed ID: 18275362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry.
    Szypowska A; Schwandt A; Svensson J; Shalitin S; Cardona-Hernandez R; Forsander G; Sundberg F; De Beaufort C; Maahs D; Maffeis C; O'Riordan SM; Krisane ID; Scharf M; Castro S; Konstantinova M; Obermannova B; Casteels K; Gökşen D; Galhardo J; Kanaka-Gantenbein C; Rami-Merhar B; Madacsy L;
    Pediatr Diabetes; 2016 Oct; 17 Suppl 23():38-45. PubMed ID: 27417128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.
    Konrad K; Thon A; Fritsch M; Fröhlich-Reiterer E; Lilienthal E; Wudy SA; Holl RW;
    Diabetes Care; 2013 Apr; 36(4):879-86. PubMed ID: 23238661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy.
    Blackman SM; Raghinaru D; Adi S; Simmons JH; Ebner-Lyon L; Chase HP; Tamborlane WV; Schatz DA; Block JM; Litton JC; Raman V; Foster NC; Kollman CR; DuBose SN; Miller KM; Beck RW; DiMeglio LA
    Pediatr Diabetes; 2014 Dec; 15(8):564-72. PubMed ID: 24494980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
    Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M
    Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus.
    Noronha RM; Damaceno N; Muramatu LH; Monte O; Calliari LE
    Pediatr Diabetes; 2014 Jun; 15(4):309-12. PubMed ID: 24256553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions.
    Rasouli N; Seggelke S; Gibbs J; Hawkins RM; Casciano ML; Cohlmia E; Taylor-Cousar J; Wang C; Pereira R; Hsia E; Draznin B
    J Diabetes Sci Technol; 2012 Sep; 6(5):1038-44. PubMed ID: 23063029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports.
    Sulli N; Bertasi S; Zullo S; Shashaj B
    J Cyst Fibros; 2007 May; 6(3):237-40. PubMed ID: 16973423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Pumps in Type 1 Diabetes with Mental Disorders: Real-Life Clinical Data Indicate Discrepancies to Recommendations.
    Prinz N; Bächle C; Becker M; Berger G; Galler A; Haberland H; Meusers M; Mirza J; Plener PL; von Sengbusch S; Thienelt M; Holl RW;
    Diabetes Technol Ther; 2016 Jan; 18(1):34-8. PubMed ID: 26451621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
    Lozano-Serrano M; García-Seco JA; García-Seco F; Lozano-Hernández MC; Seco-Segura ÁM; Moreno-Fernández J; Muñoz-Cazallas PA; Ferreiro-Vicario C; Sánchez-Covisa MA
    Enferm Clin; 2013; 23(3):96-102. PubMed ID: 23755944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
    Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L
    Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria.
    Hofer SE; Heidtmann B; Raile K; Fröhlich-Reiterer E; Lilienthal E; Berghaeuser MA; Holl RW;
    Pediatr Diabetes; 2010 Mar; 11(2):116-21. PubMed ID: 19566740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.